RA Capital Management »

Abivax SA F shares owned by RA Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $151M 1.1M 133.26

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Citadel Advisors
Darwin Global Management
Helikon Investments
Jupiter Topco
ADAR1 Capital Management
Morgan Stanley
Vestal Point Capital
Caligan Partners
Westfield Capital Management Company
FMR
Susquehanna International
RA Capital Management
Eversept Partners

View all funds holding Abivax SA F